Company spun out of UMB School of Pharmacy aims to leverage its approach — combining modern artificial intelligence (AI) with traditional mechanistic models — to arm health care professionals with the best data to provide personalized treatment trajectories for patients.

New company established by School of Pharmacy faculty members releases its first software platform designed to assist strategic decision making across the fields of drug development and individualized patient care.

International award recognizes outstanding achievements at the forefront of research or leadership in the field of pharmacometrics.

Researchers from the School of Pharmacy and Johns Hopkins University use PET scans and pharmacometric modeling to help inform dosing recommendations for first-line tuberculosis drug.

Partnership will facilitate the development of therapeutics for pediatric patients and provide research and education opportunities for faculty, students, and trainees.

FDA praises the Center’s efforts to bring academic, government, and industry stakeholders together for collaborative project with wide-reaching implications.

Gift of software will benefit students in the School’s Master of Science in Pharmacometrics program and aid researchers in the Center for Translational Medicine.